Novo fights big tax bill; Teva shares surge on Avandia recommendation;

Novo Nordisk

 @FiercePharma: Sanofi joins GSK, MedImmune with 4-in-1 flu vaccine. Article | Follow @FiercePharma

 @EricPFierce: French police are investigating death of 92-year-old man who took recalled Teva diuretic that may contain sedative. Story | Follow @EricPFierce

 @CarlyHFierce: Valeant drops bid for Serbian generics maker. More | Follow @CarlyHFierce

> Novo Nordisk ($NVO) is in a tax fight with Denmark over some of its patents. Story

> India's Supreme Court justices told a lawyer that has brought a citizen action against Ranbaxy Laboratories that he needs to put up some evidence the drugmaker is not making quality products beyond media reports tied to its $500 million settlement with U.S. regulators. Story

> Shares of Teva Pharmaceutical Industries ($TEVA) surged on the possibility that the FDA will ease restrictions on GlaxoSmithKline's ($GSK) Avandia and so Teva's generic will sell better. Story

> The European Medicines Agency has expanded approval for Roche's ($RHHBY) RoActemra to cover the treatment of children with polyarticular juvenile idiopathic arthritis. Report

Medical Device News

 @FierceMedDev: Does J&J's latest metal hip lawsuit boost the number to 10,001? Article | Follow @FierceMedDev

 @DamianFierce: Private equity firms are weighing bids for PRA as the CRO mulls an IPO. Story | Follow @DamianFierce

 @MarkHFierce: Here's my first Berlin interview - it's about a nanotech tumor treatment company called MagForce AG. Cool stuff. Editor's corner | Follow @MarkHFierce

 @MichaelGFierce: New research further reveals nano-gold's delivery potential, safety risk. More | Follow @MichaelGFierce

> Malaysia anticipates OEM growth from U.S. device clients. Item

> CareFusion emerges as potential ICU bidder. Article

Biotech News

 @FierceBiotech: Shire chief focuses on deal-making, trials with eye to revving up sales. More | Follow @FierceBiotech

 @JohnCFierce: Dynavax tumbles after FDA blocks shortcut on hepatitis B vax salvage operation. Article | Follow @JohnCFierce

 @RyanMFierce: NIH for Health, BGI, Broad Institute, others ally to share Big Data in genomics (special lack of pharma players?) More | Follow @RyanMFierce

 @EmilyMFierce: Scientists discover new antibacterial molecules to fight anthrax, TB. Report | Follow @EmilyMFierce

> Gilead gains FDA's inside track for hep C drug sofosbuvir. Item

> FDA blasts Aveo one last time for 'uninterpretable' cancer study. Report

> AstraZeneca bags another PhIII therapy in $1.15B Pearl buyout. News

CRO News

> Celerion targets biologics, vaccine studies with Irish expansion. More

> PRA draws private equity interest as IPO pends. News

> Patheon finally turns a profit after $255M Banner deal. Article

> Boehringer eyes Chinese CMO market with biologics plant. Report

Biotech IT News

> AstraZeneca bolsters software systems for virtual R&D of neuroscience drugs. Article

> NIH, BGI, others ally to share Big Data in genomics. Item

> In latest acquisition, IMS Health scoops up Incential Software. Story

> Pharma giant Boehringer Ingelheim backs startup program Rock Health. More

> GenoSpace joins growing alliance for sharing translational research data. Article

And Finally... Gilead Sciences ($GILD) has gotten fast-tracked by the FDA for consideration of its hep C drug. Story